Laddar...
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease in the Western world and is closely associated with metabolic syndrome, which includes hypertension, central obesity, dyslipidemia and insulin resistance. NAFLD includes a wide spectrum of liver alterations, ranging from...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Baishideng Publishing Group Co., Limited
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4009475/ https://ncbi.nlm.nih.gov/pubmed/24799988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i4.199 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|